May 2014

Let's Talk Mental Health

11:30am-1:30am | The Westin Ottawa - 11 Colonel By Drive, Ottawa

Join a seasoned group of healthcare professionals for an armchair discussion regarding mental health in Canada. What can we do to raise awareness of these mental health issues and how can we create an environment for citizens suffering from these illnesses to feel safe enough to talk? This discussion will look at cross disciplinary approaches to observe mental health and draw on best practices.

Panellists include Louise Bradley, President and CEO of the Mental Health Commission of Canada, Dr. Zul Merali, President and CEO of the University of Ottawa Institute of Mental Health Research, Dr. Michael Teehan, President of the Canadian Psychiatric Association, and Mary Deacon, Chair of Bell's Let's Talk Mental Health Initiative. Moderated by André Picard, Health Columnist for The Globe and Mail.

Let's Talk Mental Health

Dr. Michael Teehan

Canadian Psychiatric Association

Dr. Michael Teehan

Dr. Michael Teehan is an educator and clinician-researcher from Halifax, Nova Scotia with an abiding interest in severe and persistent mental illness. More recently his clinical work has focused on treating patients experiencing early psychosis.

Dr. Teehan is currently Deputy Head of the Department of Psychiatry and Assistant Dean for Student Affairs in the Faculty of Medicine at Dalhousie University. He has a long association with the university where he also served as Director of postgraduate training from 1994 to 1999. A native of Ireland, Dr. Teehan began his postgraduate studies in psychiatry at Trinity College Dublin, completing a final year at Dalhousie and graduating in 1984. Since that time he has been an active member of the teaching staff at the Capital District Health Authority hospitals in Halifax.

In 2002, Dr. Teehan’s clinical excellence was recognized with the Community of Scholars Award of Excellence in Clinical Practice from the Faculty of Medicine at Dalhousie and in 2003 with a Medical Staff Achievement Award from the Queen Elizabeth II Health Sciences Centre.

In addition to direct clinical care, Dr. Teehan has worked in mental health administration as Psychiatrist-in-Chief at the Camp Hill Medical Centre and as the Clinical and Academic Director of the Capital District Health Authority.

Dr. Teehan has been an active member of the Canadian Psychiatric Association since 1984. He served as the Nova Scotia representative to the Board of Directors from 1988-1994 and from 2009 to the present. In addition, he has been a member of the education, research and advocacy committees.

Dr. Teehan is also a Member of the College of Physicians in Ireland and was elected a Fellow of the College of Physicians in Ireland in 1996.

Mary Deacon

Bell Let’s Talk Mental Health Initiative

Mary Deacon

Mary Deacon is Chair of the Bell Let’s Talk mental health initiative, the largest-ever corporate initiative of its kind in Canada. Bell has committed more than $67 million to support new mental health research, workplace best practices, improved care and access, and anti-stigma programs including Bell Let’s Talk Day and Clara’s Big Ride for Bell Let’s Talk.

Mary holds a BA and is a Certified Fund Raising Executive (CFRE) of the Association of Fundraising Professionals (AFP) Foundation.

Zul Merali, Ph.D.

Vice President Research, The Royal; President & CEO, uOttawa Institute of Mental Health Research
Founding Scientific Director, Canadian Depression Research & Intervention Network

Zul Merali, Ph.D.

Zul Merali (PhD) is President/CEO and Scientific Director of the University of Ottawa Institute of Mental Health Research as well as the Founding Scientific Director of the Canadian Depression Research and Intervention Network. He is full professor in the faculties of Medicine (Departments of Cellular and Molecular Medicine and Psychiatry) and Social Sciences (Psychology) at the University of Ottawa. He is also a research professor at the Institute of Neuroscience at Carleton University. Dr. Merali’s research endeavours, supported by grants from CIHR and NSERC, strive to characterize the body’s response to stressful and appetitive events, and the relationship of stressors (including early-life trauma) to mood and anxiety disorders. Another focus of his research is to determine how pharmacological interventions (pharmaceutical and natural products) may attenuate stress-induced pathophysiology. In this vein, he and his colleagues have isolated several anti-anxiety compounds from a variety of rare plants. Dr. Merali’s research extends from the behavioural to the cellular and molecular levels, and involves experimental animals as well as human subjects. Dr. Merali has published over a hundred and eighty scientific papers, more than 20 book chapters and over 200 conference presentations.

Our Sponsors

Telus Interac Green Shield Canada